Masterstudiengang „Drug Regulatory Affairs"


Modul 04 (WS 2017 / SS 2018)

Generelle Aspekte des Modul 1 (CTD) und Zulassung besonderer Arzneimittelgruppen

Präsenzzeit Studienarbeiten Prüfungsform Leistungspunkte
ca. 30 Stunden ca. 30 Stunden Studienarbeit 5


  • Dr. Niels Krebsfänger


Regulatory Intelligence

Abridged / Generic Applications with emphasis on administrative processes and content of the dossier in module 1 

  • Essentially similar and informed consent applications
  • Bibliographical applications
  • Content of the dossier (modules 1, 2 and specific aspects for modules 3 and 4)
  • Line-extensions
  • Scientific Advice at the BfArM
  • The marketing authorization application form

Product Information Management

  • Clinical Trial reports according to Annex one of Directive 2001/83, Clinical Summary and Overview, relevant aspects in the assessment of clinical part of the dossier
  • Assessment process, e.g. efficacy (Wirksamkeitsprüfung)
  • Company Core Data Sheet
  • Summary of Product Characteristics (SmPC)
  • Package leaflet and consultation with target patient groups
  • Labelling (Kennzeichnung)
  • Labelling principles in national phases of EU procedures

Advanced Therapies

  • Relevant Directives, Regulations, Guidelines
  • Definition and classification: advanced therapy medicinal products, tissue products, combined products
  • Authorization procedures
  • Incentives


  • Definitions and specific aspects
  • Combinations
  • Influenza vaccines
  • Authorization procedure (brief introduction)

Blood products

  • Specific regulatory aspects for Blood components
  • Official Batch Release
  • Specific requirements for marketing authorization of blood products (example coagulation factors)
  • Plasma Master File

Specific aspects in marketing applications procedures for herbal and homeopathic medicinal products (Arzneimittel der besonderen Therapierichtungen)

  • Definitions
  • Requirements (AMG, AMPrüfRL, pharmacopoeas)
  • Possible MAA/registration procedures and required data on S, Q, E
  • Herbal medicinal products, HMPWP, Botanical nomenclature, Extracts (labeling)
  • Homeopathic medicinal products: the homeopathic principle, manufacturing according to PhEur
  • Registration procedure
  • Anthroposophical products (brief introduction)

Veterinary products 

  • Definitions, Veterinary Legislation in Germany, EU and globally
  • EMEA, CVMP, HMA and CMD(v), VICH, Animal Health Industry Associations
  • Specific aspects of the SmPC
  • Parts of a Dossier - Part I, II, IIIA Safety, IIIB Residues, IV
  • Withdrawal Periods
  • Ecotoxicity


Teil 1:    
Freitag   19. Januar 2018 von 8.30 - 18.30 Uhr
Samstag   20. Januar 2018 von 8.00 - 16.00 Uhr
Ort:    Haus der evang. Kirche, Adenauerallee 37, Bonn
Teil 2:    
Freitag    26. Januar 2018 von 8.30 - 18.30 Uhr
Samstag   27. Januar 2018 von 8.00 - 16.00 Uhr
    Abgabe Studienarbeit: 26.02.2018

UnterlagenNur für Mitglieder

Bitte melden Sie sich hier mit Ihren Zugangsdaten an.